Search
for
Sort by
Research 691–720 of 1000+
- Anatomical and Dermatologic Manifestations of Estrogen Deficiency in Postmenopausal Women: A Systematic Review
- MANAGING ESTROGEN-DEFICIENT SKIN: A NARRATIVE REVIEW ON THE ROLE OF HRT AND EMERGING ESTROGEN-MODULATING THERAPIES
- Menopause and aging, quality of life and sexuality
- Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective
- Chemoprävention des Prostatakarzinoms - Ein Plädoyer
- Persistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia
- Trazodone associated with Clomiphene a proposal treatment for post finasteride syndrome
- Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome
- Androgen receptor: A promising therapeutic target in breast cancer
- Recent advances in thiasteroids chemistry
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- New approaches to the treatment of osteoporosis
- A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- Hepatotoxicity Associated with Anabolic Androgenic Steroids and Selective Androgen Receptor Modulators: A Literature Review
- Abstract P5-09-21: Selective androgen receptor modulators (SARMs): Enobosarm as targeted therapy for the treatment of androgen receptor-positive breast cancer
- Selective androgen receptor modulators: a critical appraisal
- Therapeutic Androgen Receptor Ligands
- Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands
- Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus
- Androgen Receptor Ligands: Agonists and Antagonists
- 17β-Estradiol Inhibits Wound Healing in Male Mice via Estrogen Receptor-α
- Minoxidil May be a Partial Agonist of Estrogen Receptor Alpha
- Reproduction of the human relevant potency threshold (HRPT) for estrogen receptor alpha agonism in an inference performance screen for ICCVAM’s regulatory scientific confidence framework
- Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Diffuser Haarausfall und klinische Endokrinologie: Neue Erkenntnisse